Transcriptomic profiling performed in bladder carcinomas collected from Neodurvarib clinical trial (NCT03534492)
RNA-seq (gene expression) · human · 26 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Bladder cancerThis series is part of our curated briefing on it.
- Samples
- 26 samples: 16 × SCRNEO vs 10 × QNEOGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB TrialClinical cancer research : an official journal of the American Association for Cancer Research · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE225066_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA933649 and SRA study SRP421883. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 26 samples.
How we read this: 2 replicated groups read from 26 sample titles; they account for 26 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7038860 QNEO10 QNEO
- GSM7038861 QNEO1 QNEO
- GSM7038862 QNEO12 QNEO
- GSM7038863 QNEO13 QNEO
- GSM7038864 QNEO15 QNEO
- GSM7038865 QNEO16 QNEO
- GSM7038866 QNEO17 QNEO
- GSM7038867 QNEO18 QNEO
- GSM7038868 QNEO2 QNEO
- GSM7038869 QNEO5 QNEO
- GSM7038870 SCRNEO10 SCRNEO
- GSM7038871 SCRNEO11 SCRNEO
- GSM7038872 SCRNEO1 SCRNEO
- GSM7038873 SCRNEO14 SCRNEO
- GSM7038874 SCRNEO15 SCRNEO
- GSM7038875 SCRNEO16 SCRNEO
- GSM7038876 SCRNEO18 SCRNEO
- GSM7038877 SCRNEO21 SCRNEO
- GSM7038878 SCRNEO2 SCRNEO
- GSM7038879 SCRNEO22 SCRNEO
- GSM7038880 SCRNEO24 SCRNEO
- GSM7038881 SCRNEO26 SCRNEO
- GSM7038882 SCRNEO3 SCRNEO
- GSM7038883 SCRNEO4 SCRNEO
- GSM7038884 SCRNEO5 SCRNEO
- GSM7038885 SCRNEO8 SCRNEO
- GSE181389 Transcriptome profiling of HOXA13 and HOXB13 expression knockdown in bladder cancer cell lines. 59 samples same disease briefing · shares bladder
- GSE193755 Human bladder cancer cell line high throughput sequencing - genes regulated by hMSH2 12 samples same disease briefing · shares bladder
- GSE214886 Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer 12 samples same disease briefing · shares bladder
- GSE211924 UCHL5 promotes Tumorigenesis of Bladder Cancer by Activating AKT/mTOR signaling pathway and targeting c-myc, SLC25A19, and ICAM5. 9 samples same disease briefing · shares bladder
- GSE172359 Combination of urine exosomal mRNAs and lncRNAs as novel diagnostic biomarkers for bladder cancer 6 samples same disease briefing · shares bladder
- GSE182310 Transcriptome sequence of Human bladder cancer cell line 6 samples same disease briefing · shares bladder
- GSE193753 Human bladder cancer cell line high throughput sequencing - genes regulated by hMSH2 - CDDP therapy 6 samples same disease briefing · shares bladder
- GSE193754 Human bladder cancer cell line high throughput sequencing - genes regulated by hMSH2 - untreated 6 samples same disease briefing · shares bladder
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.